NANOVIRICIDES, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Nanoviricides, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q4 2013 to Q2 2024.
  • Nanoviricides, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 11.9M shares, a 2.11% increase year-over-year.
  • Nanoviricides, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 11.9M shares, a 2.11% increase from 2023.
  • Nanoviricides, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 11.6M shares, a 0.79% increase from 2022.
  • Nanoviricides, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 11.5M shares, a 5.81% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 11.9M +245K +2.11% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-27
Q1 2024 11.8M +144K +1.23% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 11.7M +136K +1.17% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 11.7M +126K +1.09% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 11.6M +91.5K +0.79% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-27
Q1 2023 11.6M +95.7K +0.83% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 11.6M +85K +0.74% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 11.6M +77.1K +0.67% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 11.5M +634K +5.81% Apr 1, 2022 Jun 30, 2022 10-K 2023-10-13
Q1 2022 11.5M +587K +5.36% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 11.5M +859K +8.06% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 11.5M +1.03M +9.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 10.9M Apr 1, 2021 Jun 30, 2021 10-K 2022-10-13
Q1 2021 11M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 10.7M Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 10.5M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2018 64.9M +4.82M +8.02% Apr 1, 2018 Jun 30, 2018 10-K 2018-10-12
Q1 2018 64.1M +3.07M +5.03% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-21
Q4 2017 63.3M +5.13M +8.81% Oct 1, 2017 Dec 31, 2017 10-Q 2018-02-20
Q3 2017 63.3M +5.13M +8.81% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-14
Q2 2017 60.1M +2.43M +4.22% Apr 1, 2017 Jun 30, 2017 10-K 2018-10-12
Q1 2017 61M +3.17M +5.47% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 58.2M +617K +1.07% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-20
Q3 2016 58.2M +906K +1.58% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 57.7M -1.55M -2.62% Apr 1, 2016 Jun 30, 2016 10-K 2018-10-12
Q1 2016 57.8M -1.77M -2.97% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 57.6M -1.64M -2.76% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 57.3M +1.7M +3.06% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 59.2M Apr 1, 2015 Jun 30, 2015 10-K 2017-09-28
Q1 2015 59.6M +4.57M +8.31% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 59.2M +9.19M +18.4% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 55.6M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q1 2014 55M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 50M Oct 1, 2013 Dec 31, 2013 10-Q/A 2015-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.